Skip to main content
Premium Trial:

Request an Annual Quote

Natera, Brazilian Hospital Ink Deal for Panorama Test

NEW YORK (GenomeWeb News) – Natera announced a deal with Hospital Israelita Albert Einstein in São Paulo to offer Natera's Panorama non-invasive prenatal test.

Financial and other terms of the deal were not disclosed.

"This test enables us to provide expecting parents with reliable information about the genetics of their baby early on in pregnancy," the hospital's Director of Maternal Fetal Medicine, Rita Sanchez, said in a statement.

Using a blood draw, Panorama examines cell-free DNA found in maternal blood and detects for trisomy 21, 18, and 13, as well as for monosomy X, triploidy, and vanishing twins.

Last week, the San Carlos, Calif.-based firm said that Panorama, along with similar tests from Illumina's Verinata Health and Ariosa Diagnostics, are being offered through the California Prenatal Screening Program. In recent months, Natera also announced distribution deals with Solstas Lab Partners and LifeLabs.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.